50
Participants
Start Date
November 30, 2008
Primary Completion Date
October 31, 2012
Study Completion Date
August 31, 2013
Trivirus Specific CTLs for EBV, CMV and Adenovirus Infection
"Follow-up Assessments: The timing of follow-up visits is based on the date of CTL infusion. If a patient has multiple CTL doses the schedule resets again at the beginning so follow up relates to the last CTL dose.~Follow up will occur at 7 days, 14 days, 21 days, 28 days, 42 days, 90 days, 180 days, and 365 days post enrollment."
Duke University Medical Center, Durham
MD Anderson Cancer Center, Houston
Texas Children's Hospital, Houston
Houston Methodist Hospital, Houston
Children's Hospital of Los Angeles, Los Angeles
University of Miami, Coral Gables
Hackensack University, Bergen County
Dana Farber Cancer Institute, Boston
Collaborators (1)
The Methodist Hospital Research Institute
OTHER
Brigham and Women's Hospital
OTHER
Massachusetts General Hospital
OTHER
M.D. Anderson Cancer Center
OTHER
National Marrow Donor Program
OTHER
The Emmes Company, LLC
INDUSTRY
Duke University
OTHER
Beth Israel Deaconess Medical Center
OTHER
Children's Hospital Los Angeles
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Boston Children's Hospital
OTHER
University of Miami
OTHER
Hackensack Meridian Health
OTHER
University of California, Los Angeles
OTHER
Baylor College of Medicine
OTHER